Wang M, Sang J, Xu F, Wang S, Liu P, Ma J
Adv Sci (Weinh). 2024; 12(4):e2413181.
PMID: 39629989
PMC: 11775548.
DOI: 10.1002/advs.202413181.
Dauki A, Rajakumaraswamy N, Trowe T, Weng W, Lin K, Elboudjwarej E
Clin Transl Sci. 2024; 17(8):e70011.
PMID: 39169685
PMC: 11339314.
DOI: 10.1111/cts.70011.
Wilkinson C, Nakano K, Grimm S, Whitehead G, Arao Y, Blackshear P
Res Sq. 2024; .
PMID: 38883724
PMC: 11177951.
DOI: 10.21203/rs.3.rs-4414130/v1.
Momenilandi M, Levy R, Sobrino S, Li J, Lagresle-Peyrou C, Esmaeilzadeh H
Cell. 2024; 187(11):2817-2837.e31.
PMID: 38701783
PMC: 11149630.
DOI: 10.1016/j.cell.2024.04.009.
Chen A, Zhu J, Liu R, Mei Y, Li L, Fan Y
Bioact Mater. 2024; 37:331-347.
PMID: 38694762
PMC: 11061616.
DOI: 10.1016/j.bioactmat.2024.03.023.
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Flynn P, Long M, Kosaka Y, Long N, Mulkey J, Coy J
Front Immunol. 2024; 15:1297338.
PMID: 38495876
PMC: 10943691.
DOI: 10.3389/fimmu.2024.1297338.
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.
Tolcher A, Brody J, Rajakumaraswamy N, Kuhne M, Trowe T, Dauki A
Clin Cancer Res. 2024; 30(14):2954-2963.
PMID: 38295150
PMC: 11247315.
DOI: 10.1158/1078-0432.CCR-23-2808.
FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis.
Regnier P, Vetillard M, Bansard A, Pierre E, Li X, Cagnard N
Cell Rep Med. 2023; 4(12):101256.
PMID: 38118422
PMC: 10772324.
DOI: 10.1016/j.xcrm.2023.101256.
Lymph node medulla regulates the spatiotemporal unfolding of resident dendritic cell networks.
Ugur M, Labios R, Fenton C, Knopper K, Jobin K, Imdahl F
Immunity. 2023; 56(8):1778-1793.e10.
PMID: 37463581
PMC: 10433941.
DOI: 10.1016/j.immuni.2023.06.020.
Early-life hyperoxia-induced Flt3L drives neonatal lung dendritic cell expansion and proinflammatory responses.
Cui T, Brady A, Zhang Y, Fulton C, Goldsmith A, Popova A
Front Immunol. 2023; 14:1116675.
PMID: 36845082
PMC: 9950736.
DOI: 10.3389/fimmu.2023.1116675.
Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy.
Cuzzubbo S, Roch B, Darrasse-Jeze G, Hosten B, Leclercq M, Vignal N
Int J Mol Sci. 2022; 23(23).
PMID: 36499300
PMC: 9738778.
DOI: 10.3390/ijms232314975.
Guidelines for mouse and human DC generation.
Lutz M, Ali S, Audiger C, Autenrieth S, Berod L, Bigley V
Eur J Immunol. 2022; 53(11):e2249816.
PMID: 36303448
PMC: 10704271.
DOI: 10.1002/eji.202249816.
Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration.
Chen L, Huang Y, Dong B, Gu Y, Li Y, Cang W
J Inflamm Res. 2022; 15:5889-5904.
PMID: 36274829
PMC: 9579815.
DOI: 10.2147/JIR.S384908.
CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple.
Hume D, Batoon L, Sehgal A, Keshvari S, Irvine K
Curr Osteoporos Rep. 2022; 20(6):516-531.
PMID: 36197652
PMC: 9718875.
DOI: 10.1007/s11914-022-00757-4.
Compromised anti-tumor-immune features of myeloid cell components in chronic myeloid leukemia patients.
Harada I, Sasaki H, Murakami K, Nishiyama A, Nakabayashi J, Ichino M
Sci Rep. 2021; 11(1):18046.
PMID: 34508131
PMC: 8433374.
DOI: 10.1038/s41598-021-97371-8.
Dendritic cells play no significant role in the laser-induced choroidal neovascularization model.
Droho S, Perlman H, Lavine J
Sci Rep. 2021; 11(1):17254.
PMID: 34446787
PMC: 8390527.
DOI: 10.1038/s41598-021-96704-x.
The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy.
Cueto F, Sancho D
Cancers (Basel). 2021; 13(7).
PMID: 33810248
PMC: 8037622.
DOI: 10.3390/cancers13071525.
Single-cell analyses reveal the clonal and molecular aetiology of Flt3L-induced emergency dendritic cell development.
Lin D, Tian L, Tomei S, Amann-Zalcenstein D, Baldwin T, Weber T
Nat Cell Biol. 2021; 23(3):219-231.
PMID: 33649477
DOI: 10.1038/s41556-021-00636-7.
Reduced circulating dendritic cells in acute Plasmodium knowlesi and Plasmodium falciparum malaria despite elevated plasma Flt3 ligand levels.
Loughland J, Woodberry T, Oyong D, Piera K, Amante F, Barber B
Malar J. 2021; 20(1):97.
PMID: 33593383
PMC: 7888183.
DOI: 10.1186/s12936-021-03642-0.
High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
Kim S, Bagadia P, Anderson 3rd D, Liu T, Huang X, Theisen D
Immunity. 2020; 53(4):759-774.e9.
PMID: 32795402
PMC: 8193644.
DOI: 10.1016/j.immuni.2020.07.018.